Rhumbline Advisers Longboard Pharmaceuticals, Inc. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Longboard Pharmaceuticals, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 42,476 shares of LBPH stock, worth $2.53 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,476
Previous 29,976
41.7%
Holding current value
$2.53 Million
Previous $647,000
77.43%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LBPH
# of Institutions
104Shares Held
34.2MCall Options Held
8.5KPut Options Held
31.1K-
Ra Capital Management, L.P. Boston, MA3.29MShares$196 Million1.34% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.94MShares$175 Million0.38% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.79MShares$167 Million5.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$150 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$141 Million0.0% of portfolio
About Longboard Pharmaceuticals, Inc.
- Ticker LBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,586,000
- Market Cap $811M
- Description
- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...